Member Info for Fruitsnveg

I disagree Doc.Dan, they are not doing nothing and I don't support a change that will destabilsie progress. As a part-owner in this company I reject tomfoolery that will interfere with pls being executed. I will caveat that by saying if there is no progress against plans laid out today by year end, I too will be demanding answers. But they be given space, IMO, to execute the plans they have drawn up and presented. Yes £7+ is still my target - I am playing the long game here so others will not be comfortable committing to timeframes that I am. I don't subscribe to your notion ta I am either naieve or apologetic. I'll be a long time dead so patience comes easily to me. I am prepared to go through the process to get there, i know this is a slow industry. Selling out now would not be financially advantageous for me either. Fair enough that others take a shorter term view on their investment. To TP's point about commercialisation - you can't sell nothing is my though. Data is still needed. Horse, cart; it only works in that order. Focus on the next step of the development path, then commercialisation. You can't have one without the other.

I get it Aether, so do I. And apologies for lumping your response in with another. i feel this is hinging more on a collaboration of sorts (just my feeling), but more time needed to let them t those plans now in motion and for us to find out. They are accountable in my book as of today, the plans worked on for the past months and laid out today are a line in the sand, but they must also be given the necessary space to execute these IMHO.

It's not rocket science. They are on board with plans, otherwise you'd have seen sweeping change and action. Actions speak louder than words. It's time to acknowledge that instead of eternally pondering what is staring you in the face. If the hedge fund gods are angered, you will know about it.

If you feel that way (which I don't), changing BOD or CEO is going to do diddly squatt. Biotech moves on data, nothing else, a change in personnel will NOT magic up trial data. Even BP get knocked back by the FDA for lack of of insufficient data. Our development path as laid out today requires focus, graft and most of all time. For sure, as in any industry project, there will be dependencies on others, out of the company's control. I find talk to replacing CEO/BOD unhealthy because disruption and change of course is not in the interests of the majority shareholders. We are on the right past, we just need to be patient. If you think about it, disruption and agitation at this point serves only the shorters. The company need to show progress by year end against the path they have laid out today. They will be held accountable, but I also think they need a chance to now realise those plans.

Spacman, I offer you the Finnish word ‘kalsarikänni’. It means drinking at home, alone, and in your underwear, courtesy of Susie D.

No change from £7 for me.
The journey has taken an unexpected scenic route, but the prize remains the same.

True, wpa5.

Doc.Dan
The prize here for our large investor (10x their investment) remains, IMO, unchanged. It is perfectly feasible to continue to lay the high stakes high reward game. It is only the route that has changed. I am watching the 37th Marathon des Sables as I type this, marvelling at the sheer strength of will, grit and determination to cross the finish line after 6 gruelling days running through 40deg Saharan desert. A beautiful but utterly brutal test of the human spirit. We must steel ourselves a little if we are to stay in this race too...prizes worth winning rarely come easy. I could be wrong, but I expect Polyg are here for the finish line.

It may very well prove to not be a case of Strive turning us down. The company may have turned down Strive (due to the slow nature of the trial apparatus. We may be an agreed future agent. We may be awaiting announcement on a different trial. WE may be gearing up to collaborate with a BP. We may be part of Prof Wilko's industry "consortium". We don't know what we don't know, so it's too early to measure the playing field IMHO.

But it's the majority holders that will steer this ship into port, not the tugboats.

Its inevitable that talk turns to the blame game, particularly with so many uninvested

Doc.Dan, Have you sen the one where Old man Roy underestimates Nan Pierce? It's sublime.

Thanks for info Doc.83. There's nothing wrong with looking at all available info to work out the art of the possible. That's what we are here for after all.

Yawn Mani. I'm perfectly happy with my +3year investment here, I think the BOD are doing a sterling job ignoring the trolls desperately trying to sink the SP, and I look forward to news very soon. I intend to make a good return here.
So you carry on doing you, and I'll carry on doing me.

It's disappointing, but unsurprising, that the self-titled "interferologist" can make no scientific commentary of note on the the data TommyD_19. Sufficiently vague, but seems to have Mani fooled...

I'm not sure which realm you are living in now; last year you claimed "There had also been a lot of work done on this at the cold research unit in Salisbury which I visited".

But now you are saying you didn't merely VISIT the CCU, but WORKED there, with David Tyrell! lol.

Your fantasy trolling of the SNG board only started in November, 9 months AFTER Sprinter trial results. You certainly forewarned NOBODY of your fantasy findings!

Muppet.

Sakura, you should write to Rick Bright and tell him of your scientific findings, and maybe the FDA and NIH and all the lead investigators involved in the study and trialling of IFN for the past decade - just so they don't all go wasting any more time on a completely ineffectual drug. LOL.

Ah yes, claimed to have nebulised alcohol in an off the shelf nebuliser last year, if memory serves me correctly. About as scientifically informed (IRL) as a box of frogs IMHO.

Yes, sort of Ghia - Here's internet take: " "Old Nell" was a playful nickname for old, worn down horses. A high strung horse became a "Nervous Nellie." The name started to be applied to fearful or nervous people: "You're acting like a nervous Nellie!" and later acquired the connotation of cowardly. In the early 1920s Sen. Frank Kellog received the nickname "Nervous Nellie" for being the only Republican Senator to support the ratification of the Treaty of Versailles. In 1966 President Johnson spoke of "Nervous Nellies" to refer to critics of his Vietnam policy, and the phrase caught on. Nervous Nellie acquired the connotation of "naysayer" and gave rise to similar terms like Negative Nellie, Naysayer Nellie, Negative Ned and Negative Nancy. In 2023 the phrase was coined on LSE bb to describe Mr.Costas, notable investor in blockbuster Biotech 'Synairgen' which later went on to become one of the .....etc " OK, I'll leave it there, just a bit of fun for today :-)